Cargando…
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment
Exploring the repertoire of peptides presented on major histocompatibility complexes (MHCs) helps identify targets for immunotherapy in many hematologic malignancies. However, there is a paucity of such data for diffuse large B-cell lymphomas (DLBCLs), which might be explained by the profound downre...
Autores principales: | Bourne, Christopher M., Mun, Sung Soo, Dao, Tao, Aretz, Zita E. H., Molvi, Zaki, Gejman, Ron S., Daman, Andrew, Takata, Katsuyoshi, Steidl, Christian, Klatt, Martin G., Scheinberg, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327544/ https://www.ncbi.nlm.nih.gov/pubmed/35561310 http://dx.doi.org/10.1182/bloodadvances.2021006069 |
Ejemplares similares
-
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
por: Hasan, Aisha N., et al.
Publicado: (2022) -
Solving an MHC allele–specific bias in the reported immunopeptidome
por: Klatt, Martin G., et al.
Publicado: (2020) -
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
por: Osman, Mohammed, et al.
Publicado: (2020) -
SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
por: Keller, Michael D., et al.
Publicado: (2020) -
Catch those antibodies before they fall
por: Shaz, Beth H., et al.
Publicado: (2020)